Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03670030
Title A Study to Test the Effectiveness of ABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Robert Ramirez
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.